These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6898488)

  • 1. [Basic principles of using progestins].
    Feldsher Akush; 1980; 45(1):48-54. PubMed ID: 6898488
    [No Abstract]   [Full Text] [Related]  

  • 2. Drospirenone (Slynd) - a new progestin-only oral contraceptive.
    Med Lett Drugs Ther; 2020 Feb; 62(1591):18-19. PubMed ID: 32022787
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basic principles of progestin use (indications and contraindications)].
    Khomasuridze AG
    Akush Ginekol (Mosk); 1979 May; (5):59-61. PubMed ID: 474913
    [No Abstract]   [Full Text] [Related]  

  • 4. Contraceptive redesign: new progestins/new regimens.
    Sulak PJ
    J Fam Pract; 2004 Sep; Suppl():S3-8. PubMed ID: 15508356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic principles of using progestins].
    Khomasuridze AG
    Med Sestra; 1979 Dec; 38(12):18-22. PubMed ID: 261196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthetic progestational hormones and their principal indications in gynecology].
    el Bakali-el Kassimi A; Achour M; Oudghiri A; Saoura L; Kharbach A; Chaoui A
    Maghrib Tibbi; 1985 Jun; 7(2):524-34. PubMed ID: 4033207
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex hormones in pregnancy.
    Darling MR; Hawkins DF
    Clin Obstet Gynaecol; 1981 Aug; 8(2):405-19. PubMed ID: 7028351
    [No Abstract]   [Full Text] [Related]  

  • 8. [The new low-dose contraceptive Logest--first impressions].
    Sirakov M
    Akush Ginekol (Sofiia); 2000; 39 Suppl 1():19-20. PubMed ID: 10948638
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of a new oral contraceptive containing drospirenone.
    Shulman LP
    J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel low-dose contraceptive - one-year's experience with Logest].
    Sirakov M
    Akush Ginekol (Sofiia); 2000; 40 Suppl 3():15-6. PubMed ID: 11519224
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of progestins. Focus on the novel progestin drospirenone.
    Thorneycroft IH
    J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic progestogens (author's transl)].
    Ghéron G
    Sem Hop; 1981 Oct 8-15; 57(37-38):1515-20. PubMed ID: 6270819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonal contraception with gestagens].
    Petersen KR; Poulsen EF
    Ugeskr Laeger; 2001 Aug; 163(34):4553-6. PubMed ID: 11530558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Third generation oral contraceptives and risk of venous thrombosis].
    Olsen J
    Ugeskr Laeger; 2002 Jan; 164(3):346. PubMed ID: 11816336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sexual abstinence of thrombosis? Comment on the controversy regarding the "pill of the 3rd generation"].
    Strobel E
    Fortschr Med; 1995 Nov; 113(33):18, 20. PubMed ID: 8575701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of juvenile uterine hemorrhages with synthetic progestins].
    Antipina NN
    Vopr Okhr Materin Det; 1975 Jul; 20(7):70-3. PubMed ID: 1220184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gestagens have become of great clinical value. Disadvantages are irregular bleeding and bad temper].
    Landgren BM
    Lakartidningen; 1999 Mar; 96(13):1578-81. PubMed ID: 10218339
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oral contraceptives and risk of myocardial infarction].
    Sørensen MB; Ottesen BS
    Ugeskr Laeger; 2002 Apr; 164(18):2415-6. PubMed ID: 12024850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.